Back to search

Netherlands· NL-0f7837881aeb

Coldrex Xylosel Neusspray 0,5 mg/ml, oplossing

A xylometazoline product containing xylometazolinehydrochloride, registered in Netherlands by Omega Pharma Nederland B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC R01AA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedColdrex Xylosel Neusspray 0,5 mg/ml, …ATCR01AA07REGISTER NO.NL-0f7837881aebPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Xylometazoline is registered in 14 of 19 countries.

Countries holding a registration under ATC R01AA07 (xylometazoline), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Xylometazoline · ATC R01AA07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
XYLOMETAZOLINEHYDROCHLORIDE
Manufacturer
Omega Pharma Nederland B.V.
Country
Netherlands (NL)
ATC code
R01AA07
ATC class
Xylometazoline
Defined daily dose
0.8 mg, N
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    107402

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for xylometazoline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Xylometazoline · interactions on record

63 records

  • 6 severe
  • 54 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • MethysergideN02CA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Xylometazoline in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All xylometazoline products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Easynasan, Easynasan Junior
  • Belgium · Nasa Rhinathiol, Nasasinuspray Abschwellend
  • Bulgaria · Ксилогел, Ксилометазолин Wzf
  • Cyprus · Hexarhinal, Nasoxyl
  • Czechia · Mar Rhino, Nasenspray
  • Germany · Hysan Schnupfenspray, Hysan Schnupfenspray Kinder
  • Denmark · Klarigen, Otrivin Junior Ukonserveret
  • Estonia · Galazolin, Mindea
  • Spain · Amidrin, Idasal
  • Finland · Nasment, Naso
  • United Kingdom (Northern Ireland) · Clear Nose Spray, Nasoclear Decongestant
  • Greece · Hexarhinal, Noselif
  • Croatia · Meralys, Meralys Duo
  • Hungary · Lolimarine Ha, Lolimarine Ha Kid
  • Ireland · Otrivine Adult, Otrivine Adult Menthol
  • Iceland · Nasogen Menthol, Nasogen Normal
  • Italy · Actifed Decongestionante, Deltarindek Decongestionante
  • Lithuania · Eucamidin, Galazolin
  • Luxembourg · Nasa Rhinathiol, Nasasinuspray Décongestionnant
  • Latvia · Galazolin, Ksilonex
  • Malta · Hysan Adults, Hysan Paediatric
  • Norway · Naso, Otrivin
  • Poland · Orinox, Orinox Ha
  • Portugal · Actifed Descongestionante Sem Conservantes, Nasex
  • Romania · Bixtonim Xylo, Bixtonim Xylo Aroma
  • Sweden · Nasoferm, Nasoferm Mentol
  • Slovenia · Maresyl, Maresyl 0,5 Mg/Ml
  • Slovakia · Mar Rhino, Olynth

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8ff60d11-5379-4c0c-99fd-c0a68135581e
GET /v1/drugs/8ff60d11-5379-4c0c-99fd-c0a68135581e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neusspray, oplossing",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h107402_smpc.pdf",
  "strength": null,
  "atc_label": "Xylometazoline",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg107402",
  "excipients": [
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "WATER, GEZUIVERD",
    "ZEEWATER, GEZUIVERD"
  ],
  "substances": [
    "XYLOMETAZOLINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h107402.pdf",
  "authorised_at": "2012/09/04",
  "procedure_number": "NL/H/1991/002",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "107402",
  "additional_monitoring": "N"
}

See everything about xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.